Search
AstraZeneca Aims to Invest $50 Billion in the U.S. by 2030
3 week ago /
Read about 0 minute
Author：小编
The British pharmaceutical giant AstraZeneca intends to invest $50 billion in the United States by 2030, with the goal of bolstering its research and development (R&D) and manufacturing capabilities in the country. This investment will encompass the construction of a new pharmaceutical production facility in Virginia, as well as the expansion of R&D and cell therapy production across multiple other states. This strategic move is a direct response to former President Trump's tariff policies, aimed at generating tens of thousands of new jobs and assisting AstraZeneca in reaching its revenue targets by 2030.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
